SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001019687-02-001729
Filing Date
2002-09-04
Accepted
2002-09-04 17:20:36
Documents
13

Document Format Files

Seq Description Document Type Size
1 peregrine_s3-090302.txt S-3 112156
3 peregrine_s3-ex51.txt EX-5.1 1950
4 peregrine_s3ex10-77.txt EX-10.77 103465
5 peregrine_s3ex10-78.txt EX-10.78 85344
6 peregrine_s3ex10-79.txt EX-10.79 55578
7 peregrine_s3ex10-80.txt EX-10.80 44325
8 peregrine_s3ex10-81.txt EX-10.81 44304
9 peregrine_s3ex10-82.txt EX-10.82 35251
10 peregrine_s3ex10-83.txt EX-10.83 88736
11 peregrine_s3ex10-84.txt EX-10.84 54623
12 peregrine_s3ex10-85.txt EX-10.85 44273
13 peregrine_s3ex10-86.txt EX-10.86 35294
14 peregrine_s3-ex232.txt EX-23.2 854
  Complete submission text file 0001019687-02-001729.txt   708966
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: S-3 | Act: 33 | File No.: 333-99157 | Film No.: 02756812
SIC: 2835 In Vitro & In Vivo Diagnostic Substances